|Articles|November 3, 2014
So Who’s in Charge of Medicines in Brussels?
So now we know who is to do what on health issues in the new European Commission. Or do we?
Advertisement
So now we know who is to do what on health issues in the new European Commission. Or do we?
The furor that the new boss of the commission, Jean-Claude Juncker, unleashed with the plans for his new team, weeks before it took office, is still reverberating around Brussels. Peter O’ Donnell reports on the fallout in
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Icotyde as Treatment of Moderate-to-Severe Plaque Psoriasis in Adults and Adolescents
2
Conflict in Middle East Disrupts Pharma Drug Supplies: Report
3
U.S. Measles Outbreak Highlights Growing Vaccine Hesitancy: Q&A With Jeanne Marrazzo
4
How Are Automation and AI Impacting the Timeline From Prescription to Starting Treatment?
5